Radioactive colloidal gold in the treatment of ovarian carcinoma
Aure, Høeg, and Kolstad investigated the use of radioactive colloidal gold as a treatment modality for ovarian carcinoma in their 1971 study published in Acta Oncologica.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This 1971 study evaluated the efficacy of radioactive colloidal gold for treating ovarian carcinoma at the Norwegian Radium Hospital. The researchers administered the radiocolloid to patients with advanced disease, aiming to assess tumor response and survival outcomes using early intraperitoneal radioisotope therapy techniques. The paper reports on clinical responses and toxicity profiles associated with this specific treatment modality during that historical period. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Full text
1,882 characters
· extracted from
oa-doi-fallback
· click to expand
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
MeSH descriptors
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
References (12)
- doi:10.1148/61.6.922 via crossref
- doi:10.1016/0002-9378(71)90844-1 via crossref
- doi:10.1016/0002-9378(67)90299-2 via crossref
- doi:10.1007/978-3-642-87755-1_21 via crossref
- doi:10.1002/1097-0142(196708)20:8<1195::aid-cncr2820200803>3.0.co;2-u via crossref
- doi:10.1016/0002-9378(65)90086-4 via crossref
- doi:10.1016/0002-9378(67)90174-3 via crossref
- doi:10.1016/0002-9378(66)90116-5 via crossref
- doi:10.1016/0002-9378(49)90201-x via crossref
- doi:10.1007/978-3-642-87755-1_16 via crossref
- doi:10.1007/978-3-642-87755-1_1 via crossref
- doi:10.1016/0002-9378(68)90535-8 via crossref
Source provenance
- crossref
- last seen: 2026-08-13T06:47:13.063808+00:00
- europepmc
- last seen: 2026-11-01T09:25:17.647243+00:00
- pubmed
- last seen: 2026-10-08T21:57:15.771029+00:00
- unpaywall
- last seen: 2026-08-07T06:39:35.550527+00:00
Courtesy of the U.S. National Library of Medicine